Privileged Scaffolds in Drug Discovery

Β· Β·
Β· Elsevier
Π•-књига
850
Π‘Ρ‚Ρ€Π°Π½ΠΈΡ†Π°
Π˜ΡΠΏΡƒΡšΠ°Π²Π° условС
ΠžΡ†Π΅Π½Π΅ ΠΈ Ρ€Π΅Ρ†Π΅Π½Π·ΠΈΡ˜Π΅ нису Π²Π΅Ρ€ΠΈΡ„ΠΈΠΊΠΎΠ²Π°Π½Π΅ Β Π‘Π°Π·Π½Π°Ρ˜Ρ‚Π΅ вишС

О овој С-књизи

Privileged Scaffolds in Drug Discovery is the most complete and up-to-date work in the area. Covering a wide range of privileged structures, it is a perfect reference for scientists involved in targeted drug development. The editors recruited epserts from several prestigious Chinese institutions to cover the areas of antiviral drugs, chalcone, pyrimidine, (benz)imidazoles, natural product-derived privileged scaffolds, N-Sulfonyl carboxamides, kinase inhibitors, antitumor molecules, antineurodegenerative drugs, triazoles, oxazolidinone, indole and indoline scaffolds, tigliane diterpenoids, peptide and peptide-based drugs, quassinoids, and others including pseudonatural products, macrocycles, stable peptides and peptidomimetics. The book also explores scaffolds in drug molecules approved in recent years. Privileged Scaffolds in Drug Discovery is a complete reference for researchers in drug discovery and organic synthesis, in academic and corporate settings, who are investigating privileged structures upon which to base new drugs. Researchers in medicinal chemistry and chemical biology will also find the contents of this book valuable. - Provides wide coverage of privileged scaffolds in new drug discovery - Includes complex and diverse natural product scaffolds - Covers applications to peptides and peptide-based drugs

О Π°ΡƒΡ‚ΠΎΡ€Ρƒ

Professor Bin Yu obtained his PhD degree from Zhengzhou University and University of Cambridge and currently is a professor of medicinal chemistry at School of Pharmaceutical Sciences, Zhengzhou University. His research interests focus on chemistry driven drug discovery for novel therapeutics. To date, he has published over 120 papers in international high-impact peer-reviewed journals including Journal of Medicinal Chemistry, Organic Letters, Pharmacology & Therapeutics, Journal of Hematology & Oncology, Drug Discovery Today, Acta Pharmaceutica Sinica B, etc., 10 of them were published in journal with impact factor (IF) >10.

Professor Ning Li is the associate dean of Chinese Materia Medica of Shenyang Pharmaceutical University, the "Youth talent" of Liao Ning Revitalization Talents Program, the "Talent of Hundred level" of Liaoning Bai Qian Wan Talents Program, the "Leading talent" of both Shenyang High-Level Talent Program and Xinjiang Uygur Autonomous Region. She has focused on the research of chemoprevention of critical diseases, especially the neurodegenerative disease and cancer, through post-transcriptional mechanism on the perspective view of β€˜preventive treatment strategy’ of the Traditional Chinese theory. She has hosted seven projects of National Natural Science Foundation of China and published more than 120 SCI papers on famous academic journals, born several prizes like the "First Prize of Provincial Science and technology progress award", and obtained the authorization of 20 invention patents.

Professor Caiyun Fu obtained her PhD degree from Lanzhou university and currently is a professor of biology and deputy director of the College of Life Sciences and Medicine, director of the Research Institute for Polypeptide and Protein Pharmaceutical Products, Zhejiang Sci-Tech University. Her research interests focus on screening and identification of tumor targets and exploration of targeted intervention and developing new drugs of peptides by synthetic biology. To date she has published 34 academic papers as corresponding author or first author in international high-impact peer-reviewed journals, including Proceedings of the National Academy of Sciences of the United States of America, Advanced Science, Journal of the American Chemical Society, Angewandte Chemie International Edition, Signal Transduction and Targeted Therapy, etc

ΠžΡ†Π΅Π½ΠΈΡ‚Π΅ ΠΎΠ²Ρƒ Π΅-ΠΊΡšΠΈΠ³Ρƒ

ΠˆΠ°Π²ΠΈΡ‚Π΅ Π½Π°ΠΌ својС ΠΌΠΈΡˆΡ™Π΅ΡšΠ΅.

Π˜Π½Ρ„ΠΎΡ€ΠΌΠ°Ρ†ΠΈΡ˜Π΅ ΠΎ Ρ‡ΠΈΡ‚Π°ΡšΡƒ

ΠŸΠ°ΠΌΠ΅Ρ‚Π½ΠΈ Ρ‚Π΅Π»Π΅Ρ„ΠΎΠ½ΠΈ ΠΈ Ρ‚Π°Π±Π»Π΅Ρ‚ΠΈ
Π˜Π½ΡΡ‚Π°Π»ΠΈΡ€Π°Ρ˜Ρ‚Π΅ Π°ΠΏΠ»ΠΈΠΊΠ°Ρ†ΠΈΡ˜Ρƒ Google Play књигС Π·Π° Android ΠΈ iPad/iPhone. Аутоматски сС ΡΠΈΠ½Ρ…Ρ€ΠΎΠ½ΠΈΠ·ΡƒΡ˜Π΅ са Π½Π°Π»ΠΎΠ³ΠΎΠΌ ΠΈ ΠΎΠΌΠΎΠ³ΡƒΡ›Π°Π²Π° Π²Π°ΠΌ Π΄Π° Ρ‡ΠΈΡ‚Π°Ρ‚Π΅ онлајн ΠΈ ΠΎΡ„Π»Π°Ρ˜Π½ Π³Π΄Π΅ Π³ΠΎΠ΄ Π΄Π° сС Π½Π°Π»Π°Π·ΠΈΡ‚Π΅.
Π›Π°ΠΏΡ‚ΠΎΠΏΠΎΠ²ΠΈ ΠΈ Ρ€Π°Ρ‡ΡƒΠ½Π°Ρ€ΠΈ
ΠœΠΎΠΆΠ΅Ρ‚Π΅ Π΄Π° ΡΠ»ΡƒΡˆΠ°Ρ‚Π΅ Π°ΡƒΠ΄ΠΈΠΎ-књигС ΠΊΡƒΠΏΡ™Π΅Π½Π΅ Π½Π° Google Play-Ρƒ ΠΏΠΎΠΌΠΎΡ›Ρƒ Π²Π΅Π±-ΠΏΡ€Π΅Π³Π»Π΅Π΄Π°Ρ‡Π° Π½Π° Ρ€Π°Ρ‡ΡƒΠ½Π°Ρ€Ρƒ.
Π•-Ρ‡ΠΈΡ‚Π°Ρ‡ΠΈ ΠΈ Π΄Ρ€ΡƒΠ³ΠΈ ΡƒΡ€Π΅Ρ’Π°Ρ˜ΠΈ
Π”Π° бистС Ρ‡ΠΈΡ‚Π°Π»ΠΈ Π½Π° ΡƒΡ€Π΅Ρ’Π°Ρ˜ΠΈΠΌΠ° којС користС Π΅-мастило, ΠΊΠ°ΠΎ ΡˆΡ‚ΠΎ су Kobo Π΅-Ρ‡ΠΈΡ‚Π°Ρ‡ΠΈ, Ρ‚Ρ€Π΅Π±Π° Π΄Π° ΠΏΡ€Π΅ΡƒΠ·ΠΌΠ΅Ρ‚Π΅ Ρ„Π°Ρ˜Π» ΠΈ прСнСсСтС Π³Π° Π½Π° ΡƒΡ€Π΅Ρ’Π°Ρ˜. ΠŸΡ€Π°Ρ‚ΠΈΡ‚Π΅ Π΄Π΅Ρ‚Π°Ρ™Π½Π° упутства ΠΈΠ· Ρ†Π΅Π½Ρ‚Ρ€Π° Π·Π° ΠΏΠΎΠΌΠΎΡ› Π΄Π° бистС ΠΏΡ€Π΅Π½Π΅Π»ΠΈ Ρ„Π°Ρ˜Π»ΠΎΠ²Π΅ Ρƒ ΠΏΠΎΠ΄Ρ€ΠΆΠ°Π½Π΅ Π΅-Ρ‡ΠΈΡ‚Π°Ρ‡Π΅.